Security key
49721T507
Kiora Pharmaceuticals, Inc. - Common Stock, par value $0.01 per share (KPRX)
CUSIP: 49721T507
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 706,945
- Total 13F value
- $1,392,679
- Share change
- +90,776
- SEC-reported price per share
- $1.97
- Number of holders
- 19
- Value change
- +$165,896
- Number of buys
- 9
- Number of sells
- 6
- Shares outstanding
- 4,801,798
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
19
Top holders
10
KPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
KIORA PHARMACEUTICALS INC SEC filings
KIORA PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 49721T507
Recent filing periods:
Ownership snapshot
Top reported holders of KPRX - Kiora Pharmaceuticals, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rosalind Advisors, Inc.
Disclosed value leader
ADAR1 Capital Management,...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Rosalind Advisors, Inc.
Showing 1-6 of 15 holder rows.
Quick read
Rosalind Advisors, Inc. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rosalind Advisors, Inc.'s linked filing trail.
Comparable ownership
Top 5
Rosalind Advisors, Inc.
9.9%
Orin Hirschman
4.9%
GOLDMAN SACHS GROUP INC
0%
ADAR1 Capital Management, LLC
3.5%
Nantahala Capital Management, LLC
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. |
13D/G
|
9.9%
|
—
464,676 shares
|
$0 | 31 Dec 2025 |
| Orin Hirschman |
13D/G
|
4.9%
|
$380,178
192,984 shares
|
-$123,265 | 31 Dec 2025 |
| GOLDMAN SACHS GROUP INC |
13D/G
THE GOLDMAN SACHS GROUP, INC.
|
0%
|
$429
130 shares
|
$0 | 31 Dec 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
3.5%
|
$466,876
167,941 shares
|
— | 30 Sep 2025 |
| Nantahala Capital Management, LLC |
13F
Company
|
3.3%
|
$434,867
156,427 shares
|
— | 30 Sep 2025 |
| Stonepine Capital Management, LLC |
13F
Company
|
2.9%
|
$390,862
140,598 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
706,945
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
17
Q4 2025 holders
19
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend